I am a Senior Medical Lead in the focus area of Cardiovascular, Renal and Metabolism (CVRM) at AstraZeneca. In short, I work to get our new diabetes treatments approved worldwide. This involves, among other things, conducting clinical trials, presenting data for medical authorities and publishing trial results in various medical journals.


I started at AstraZeneca's R&D site in Lund at the end of 2009 as a Global Safety Physician. When the site in Lund was closed and certain operations were relocated to AstraZeneca in Gothenburg, I chose to also move to be able to continue my work. 


2020欧洲杯体育足球滚球比分I very much like my work, so we decided to move the whole family to Gothenburg. For me, it was an opportunity to extend my work in a field I am really passionate about; Cardiovascular, Renal and Metabolism (CVRM).

Ella Ekholm Senior Medical Lead, Late-stage Development, CVRM, BioPharmaceuticals R&D

Within BioPharmaceuticals R&D, medicines are developed from idea to market approval. After three years in AstraZeneca´s Patient Safety department, I began working as a study physician, and later became Senior Medical Lead.

I am a double specialist in internal medicine and endocrinology, and came to AstraZeneca from Malmö University Hospital, where I conducted clinical work within internal medicine and endocrinology. I received my Ph.D. for preclinical diabetes research from Uppsala University, and I am an Associate Professor in endocrinology at Lund University. I also hold a degree in Pharmaceutical Medicine (ECPM) from the University of Basel. 


2020欧洲杯体育足球滚球比分I really enjoy the diversity in my work here. If you are interested in diabetes research, BioPharmaceuticals R&D is one of the most interesting places to be right now.

Ella Ekholm Senior Medical Lead, Late-stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D